Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Food and Drug Administration classified BPC-157 as a Category 2 bulk drug substance
We attempted to fully antagonize the extensive toxicity caused by NSAIDs (using diclofenac as a prototype)
This creates additional uncertainty when evaluating both safety and clinical outcomes
Background and Mechanisms of Action BPC-157 BPC-157 was first characterized and isolated from gastric mucosal extracts and enzymatic preparations in the 1990s through systematic protein fractionation studies
Spot-checking one vial per run is industry standard
US$ 23.14
US$ 23.59
US$ 28.78
US$ 20.38
US$ 23.26
